Navigation Links
New Anti-TNF Golimumab Significantly Reduced Signs and Symptoms of Ankylosing Spondylitis According to Phase 3 Study Findings
Date:11/7/2007

cember 31, 2006. Copies of this Form 10-K, as well as subsequent filings, are available online at http://www.sec.gov, http://www.jnj.com or on request from Johnson & Johnson. Johnson & Johnson does not undertake to update any forward-looking statements as a result of new information or future events or developments.)

About Schering-Plough

Schering-Plough is a global science-based health care company with leading prescription, consumer and animal health products. Through internal research and collaborations with partners, Schering-Plough discovers, develops, manufactures and markets advanced drug therapies to meet important medical needs. Schering-Plough's vision is to earn the trust of the physicians, patients and customers served by its approximately 33,500 people around the world. The company is based in Kenilworth, N.J., and its Web site is http://www.schering-plough.com.

SCHERING-PLOUGH DISCLOSURE NOTICE: The information in this press release contains certain "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements related to the potential of golimumab. Forward-looking statements relate to expectations or forecasts of future events. Schering-Plough does not assume the obligation to update any forward-looking statement. Many factors could cause actual results to differ materially from Schering-Plough's forward- looking statements, including market forces, economic factors, product availability, patent and other intellectual property protection, current and future branded, generic or over-the-counter competition, the regulatory process, and any developments following regulatory approval, among other uncertainties. For further details and a discussion of risks and uncertainties that may impact forward-looking statements, see Sche
'/>"/>

SOURCE Centocor, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
2. DEFLUX(R) Significantly Reduces Urinary Tract Infections in Children With Vesicoureteral Reflux
3. Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
4. Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
5. Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
6. New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes
7. Promising Phase 3 Trial Results Show Novel Biologic Therapy Ustekinumab (CNTO 1275) Significantly Improved Psoriasis
8. INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients
9. New Data Published in Neurology Show Once-Daily Lamictal XR Significantly Reduced Partial Seizures in Patients with Epilepsy
10. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
11. A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... , July 7, 2015   ICD-10 Charts ... months of development, it has officially launched its ... Charts Training Academy and the new 4 Step ... well as all other ICD-10 Charts resources and ... in America, completely free-of-charge.  With the release of ...
(Date:7/7/2015)... 2015 Research and ... the "Elemental Analysis Market by Type (Organic, ... Application (Life Sciences, Food and Beverage Testing, Environment ... report to their offering. The ... types, technologies, and applications. By type, the market ...
(Date:7/7/2015)... and FREMONT, Calif. , July 7, ... South Korea and Velos, Inc. have entered into ... eResearch for cancer research nationally throughout South Korea ... The recent agreement signing was accompanied by a two day ... , South Korea.  National Cancer Center President ...
Breaking Medicine Technology:ICD-10 Charts Releases Revolutionary Free Solution for Complete ICD-10 Preparation 2ICD-10 Charts Releases Revolutionary Free Solution for Complete ICD-10 Preparation 3ICD-10 Charts Releases Revolutionary Free Solution for Complete ICD-10 Preparation 4Elemental Analysis (Organic, Inorganic) Market 2015 - Analysis & Global Forecasts to 2020 2National Cancer Center of South Korea and Velos Sign Long-Term Velos eResearch Agreement 2National Cancer Center of South Korea and Velos Sign Long-Term Velos eResearch Agreement 3
... Oct. 6 According to Millennium Research Group ... intelligence, growth in the $2 billion US cardiac ... the expanded approval of Boston Scientific,s chronic resynchronization ... I and II patients. The New ...
... Oct. 6 e-MDs, an industry leader in ... (EHRs) and practice management (PM) solutions,  congratulates  the ... Family Medicine of Fort Collins, CO, for their ... of Excellence recipients.  The Healthcare Information and Management ...
Cached Medicine Technology:Positive Results From the MADIT-CRT Trial Support the Expanding Approval of Cardiac Resynchronization Therapy Defibrillators 2Positive Results From the MADIT-CRT Trial Support the Expanding Approval of Cardiac Resynchronization Therapy Defibrillators 3e-MDs Clients Win HIMSS Davies Awards of Excellence 2e-MDs Clients Win HIMSS Davies Awards of Excellence 3e-MDs Clients Win HIMSS Davies Awards of Excellence 4
(Date:7/7/2015)... ... ... Ticket Down is a reputable source of authentic tickets for the 2015 CONCACAF Gold Cup ... at the Toyota Stadium. , The 2015 CONCACAF Gold Cup is now upon us ... held on American soil, will kick off in Frisco, CA from the Toyota Stadium and ...
(Date:7/7/2015)... ... , ... The United States Centers for Disease Control and Prevention have awarded ... Multicultural AIDS Coalition $3.78 million for a five-year HIV prevention partnership that will ... transgender women, the groups at highest risk of HIV infection in the US. ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... group whose board is limited to permit holders. The Medical Cannabis Alliance of ... move the industry forward and are committed to making sure patients have access ...
(Date:7/7/2015)... , ... July 07, 2015 , ... Safe Catch is ... single fish for mercury. Albertsons, Gelson’s Markets, New Leaf Community Markets, Sprouts Farmers Market ... , “We developed the technology to test every fish for mercury,” said Safe Catch ...
(Date:7/7/2015)... ... 07, 2015 , ... On Saturday, May 16th, 2015, the Manistee, MI chapter ... Country Club. Best Drug Rehabilitation staff members were delighted to join in for this ... International, the parent of the Manistee Kiwanis Club, is a global organization that works ...
Breaking Medicine News(10 mins):Health News:Panama vs Haiti & USA vs Honduras CONCACAF Group A Tickets at Toyota Stadium: Ticket Down Slashes Ticket Prices for Haiti vs Panama & USA vs Honduras in Frisco/Dallas 2Health News:Panama vs Haiti & USA vs Honduras CONCACAF Group A Tickets at Toyota Stadium: Ticket Down Slashes Ticket Prices for Haiti vs Panama & USA vs Honduras in Frisco/Dallas 3Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 2Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 3Health News:Cannabis Growers and Dispensaries Form Medical Cannabis Alliance of Illinois 2Health News:Safe Catch Launches Tuna with Lowest Mercury Limit of Any Brand 2Health News:Best Drug Rehabilitation Team Participates in Kiwanis Club Golf Outing Fundraiser 2
... negative (benign) MRI-guided vacuum assisted breast biopsy may not be ... Yale New Haven Hospital in Connecticut, included 144 patients with ... 36 months. The study found no malignancies on follow-up ... of the study. Two patients had suspicious findings at follow-up ...
... HealthDay Reporter , THURSDAY, May 3 (HealthDay News) ... that regardless of how "full" a person may feel, ... overeating when tempted by yummy foods. The study ... eight participants, and the authors acknowledge that their findings ...
... be a primary cause of uncontrollable tumor growth in some ... authors, findings run counter to widely accepted beliefs that genetic ... or low oxygen levels in cells, is proven to be ... for curing the malignant growth could change in significant ways, ...
... Researchers at Albert Einstein College of Medicine of ... that levels of certain related proteins found in blood are associated ... up to a decade or more later. The findings, published ... a new front in the war against diabetes. These ...
... HealthDay Reporter , THURSDAY, May 3 (HealthDay News) -- When ... inflammation, and during the first 10 years with the disease ... kidney problems. Because kidney inflammation (also called lupus nephritis) ... of Rheumatology has issued new guidelines for the screening and ...
... presentations that will be given by researchers from ... American Psychiatric Association (APA) annual meeting in Philadelphia ... Lawrence C. Kolb Professor and chairman of the ... and NewYork-Presbyterian Hospital/Columbia and director of the New ...
Cached Medicine News:Health News:Why You Overeat Even When You're Full 2Health News:Why You Overeat Even When You're Full 3Health News:Low oxygen levels could drive cancer growth 2Health News:Low oxygen levels could drive cancer growth 3Health News:Study identifies possible protective blood factors against Type 2 diabetes 2Health News:New Guidelines Issued for Severe Lupus 2Health News:New Guidelines Issued for Severe Lupus 3Health News:Columbia University Medical Center and NY-Presbyterian experts at APA meeting 2Health News:Columbia University Medical Center and NY-Presbyterian experts at APA meeting 3
The 920M PLUS handheld pulseoximeter provides on-the-spot bloodoximetry and heart rate readings....
Rad-5 signal extraction pulse oximeter™...
... 3100 is a small, lightweight ... worn comfortably on the patients ... activities and for overnight studies, ... WristOx is intended to give ...
The pocket-size Invacare Digit finger pulse oximeter is a convenient and economical solution to fast, reliable SpO2, pulse rate and pulse strength measurements. Its compact size is ideal for home use...
Medicine Products: